Procept BioRobotics: Filling Robots Slower Than Placing Them
Procept Biorobotics Corp PRCT
$18.62
▲ +3.44%
(+$0.62)
⬆️ Above Yest. High
📅 Earnings This Week
Open
$18.01
Prev Close
$18.00
Day Range
$17.71 – $18.67
52W Range
$16.67 – $51.38
Market Cap
$1.06B
Beta
0.92
EPS (TTM)
$-1.83
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2021-09-15 |
| Shares Out. | 56,920,000 |
| Website | procept-biorobotics.com/ ↗ |
| Phone | 18887167274 |
| Employees | 888 |
| Revenue | $83.1M |
| Gross Profit | $53.9M |
| Net Income | -$31.6M |
| Free Cash Flow | -$80.6M |
| Total Assets | $487.1M |
| Total Liabilities | $139.4M |
| Equity | $347.7M |
About Procept Biorobotics Corp
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
Procept Biorobotics Corp is a publicly traded company under the ticker symbol PRCT on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
22 analysts (2026-07-01)